Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer - Wikidata - wikimedia - TriplyDB

Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer

Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer

http://www.wikidata.org/entity/Q35982462

about

Bioabsorbable polymers in cancer therapy: latest developments Biosafe nanoscale pharmaceutical adjuvant materials Precisely Molded Nanoparticle Displaying DENV-E Proteins Induces Robust Serotype-Specific Neutralizing Antibody Responses Lipid-based surface engineering of PLGA nanoparticles for drug and gene delivery applications Analysis of human innate immune responses to PRINT fabricated nanoparticles with cross validation using a humanized mouse model Biodistribution and Toxicity Studies of PRINT Hydrogel Nanoparticles in Mosquito Larvae and Cells Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Polymeric Nanostructures for Imaging and Therapy Composite nanoparticles for gene delivery.Update on current and potential nanoparticle cancer therapies Nanodiamond-DGEA peptide conjugates for enhanced delivery of doxorubicin to prostate cancer.Future of the particle replication in nonwetting templates (PRINT) technology Analysis of the murine immune response to pulmonary delivery of precisely fabricated nano- and microscale particles.Polymeric nanoparticles for targeted radiosensitization of prostate cancer cells Biodistribution and trafficking of hydrogel nanoparticles in adult mosquitoes.Shape Control in Engineering of Polymeric Nanoparticles for Therapeutic Delivery.Shaping the future of nanomedicine: anisotropy in polymeric nanoparticle design A Multi-RNAi Microsponge Platform for Simultaneous Controlled Delivery of Multiple Small Interfering RNAs Reductively Responsive Hydrogel Nanoparticles with Uniform Size, Shape, and Tunable Composition for Systemic siRNA Delivery in Vivo.Targeted delivery of siRNA-generating DNA nanocassettes using multifunctional nanoparticles.Generating Better Medicines for Cancer.Ultrasound-Guided Delivery of siRNA and a Chemotherapeutic Drug by Using Microbubble Complexes: In Vitro and In Vivo Evaluations in a Prostate Cancer Model.Chaperonin-Dendrimer Conjugates for siRNA Delivery.Lipid-modified aminoglycoside derivatives for in vivo siRNA delivery.RNA replicon delivery via lipid-complexed PRINT protein particles.Pharmacogenomics-based RNA interference nanodelivery: focus on solid malignant tumors.Intelligent design of multifunctional lipid-coated nanoparticle platforms for cancer therapy.Merging the best of both worlds: hybrid lipid-enveloped matrix nanocomposites in drug delivery.Enhancing endosomal escape for nanoparticle mediated siRNA delivery.Lipid-coated polymeric nanoparticles for cancer drug delivery.Biomimetic particles as therapeutics.Multi-walled carbon nanotubes: A cytotoxicity study in relation to functionalization, dose and dispersion.An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection.Using [1-(13) C]lactic acid for hyperpolarized (13) C MR cardiac studies.Ultra-small lipid-polymer hybrid nanoparticles for tumor-penetrating drug delivery.Nanosensors for Continuous and Noninvasive Monitoring of Mesenchymal Stem Cell Osteogenic Differentiation.An automated multidimensional thin film stretching device for the generation of anisotropic polymeric micro- and nanoparticles.Targeted delivery system of nanobiomaterials in anticancer therapy: from cells to clinics.Engineered PRINT(®) nanoparticles for controlled delivery of antigens and immunostimulants.Direct Delivery of Recombinant Pin1 Protein Rescued Osteoblast Differentiation of Pin1-Deficient Cells.

P2860

Q26775714-C26A20D0-1575-4FC7-A1EE-C94FCB0708E8 Q26829798-9549C217-B1AB-4598-867A-E3C66D5BC661 Q27493140-641CD49E-7986-4CAA-8932-BBFDC2E6D566 Q28076544-AB31022F-3698-47E6-8AD2-9A45B43024BA Q28391210-5E93548A-84C5-4A81-8516-1D297D189579 Q28547397-1D4C998B-8F64-4B98-9F7F-4C9DA93F851B Q30366990-C941A448-1D87-4394-8859-6494FAA1D410 Q30372383-FC3DF199-88F5-4EBB-9301-5D1ACA66DA8C Q30374988-0EFBF4C2-7B5D-483F-8EC3-DE833C0D40B9 Q33874239-A4819DA6-0616-4DFF-945B-1D38A8EA6333 Q34082211-381BA035-2905-4EAC-90F0-EF431B91D106 Q34149094-963705A8-517A-4F37-A941-009DD0C578F6 Q34675068-C868DE10-BE12-4B30-AF96-E2446E625EC5 Q35040431-0EEC376B-F40D-4FBE-A67E-90493A19223F Q35634217-6CC6A98A-E1C5-424B-9FD4-36C0447CD3CD Q35801327-A0F08F2D-66B4-4364-A9D7-9FC143E47076 Q36279715-665BC429-E828-48D0-B2EA-0B6362EA3ACA Q36622859-AC542C0F-CEF7-4BFE-82CE-E29B50534CB1 Q36821612-A1721310-9174-43F3-9C86-D5E39224588A Q36906374-5CFE101D-71F3-4707-92BA-DC288461E18B Q36922604-F9D28812-5C5F-46DE-A880-1B2E296233C9 Q37073531-C85D87F8-E5FD-4BEC-B239-106A975FCC73 Q37394496-E0929BAE-068D-4195-8BE9-3AB2B859304C Q37503581-A3CFFEB4-FFB5-4125-9157-8DD1BE0EB763 Q37628162-022CD376-1374-4725-AD12-80319D244AC4 Q38015528-700F5C6D-DE4B-42A9-AD1A-5E52C3ED84C3 Q38074442-C9942B22-2A34-45BE-A166-017295ED8498 Q38150118-0205A2FF-AD07-4C73-9F0E-0587AED655FF Q38212473-C242A48E-8861-406C-8AA3-A91930B6583F Q38556750-C0FAB2D0-F75D-42BF-9921-0BFF8B76DAA6 Q38567436-D5C05CE2-6155-4740-90AA-61F509AF6A8C Q38704289-3F3EC661-25A7-42C8-871E-8F6B927DD423 Q38866173-E2494F16-8BA4-488B-B30D-BEE93D272561 Q39156315-985DF1BF-0B8F-47DA-BBCC-06BBBA64C94E Q39605246-A6C0E005-2338-4FB5-B1B0-E468EE1D7669 Q40118396-40AD465C-6188-4082-BC6F-3C6454CDC5EE Q41495734-85136A43-D21E-47FC-B4E9-62413D8A9A80 Q41953738-0EE7BC9A-D9A2-4591-9625-4F2F6B441B1E Q42206456-87BDD360-6FAD-4D59-9BED-018AE3A11EC0 Q42806074-B57DF13A-81E3-498A-91A2-609F02EABABC

P2860

Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer

http://www.wikidata.org/entity/Q35982462

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Delivery of multiple siRNAs us ...... r treatment of prostate cancer

@ast

Delivery of multiple siRNAs us ...... r treatment of prostate cancer

@en

type

label

Delivery of multiple siRNAs us ...... r treatment of prostate cancer

@ast

Delivery of multiple siRNAs us ...... r treatment of prostate cancer

@en

prefLabel

Delivery of multiple siRNAs us ...... r treatment of prostate cancer

@ast

Delivery of multiple siRNAs us ...... r treatment of prostate cancer

@en

P1433

Q35982462-69FADAE7-6C0E-4877-9AE7-421860352A18

P1476

Q35982462-CCB1D0C4-91EE-4514-AAD5-45238415A906

P2093

Q35982462-201B2DAC-BF35-4447-A6DC-35C170B4F1D6

Q35982462-358FF468-DCA3-4B75-A3B2-3D69192421CA

Q35982462-50CCE2BF-25BA-4085-99B7-202AA3D0FE19

Q35982462-585007D0-0B93-459E-BA78-A3E82A73EF86

Q35982462-828184D6-9AE0-4E4E-94F5-A64AC15780C1

Q35982462-94C88055-5CF2-4A55-A9EB-49440A5B3ABE

Q35982462-9F6091CA-45BE-4F33-A7C1-71D540F4CF6D

Q35982462-C11AF593-E4BE-41D6-A1A0-4CD0D77B8901

Q35982462-C1BE44AE-CE64-4E50-A927-0B04EEBF5E48

Q35982462-DEF7A8B3-7AEB-4F2D-9391-797B4873F69F

P2860

Q35982462-078EC317-6277-447E-BD07-305B5DA25969

Q35982462-0DBE40D6-5913-4D80-A7FD-184026C746BD

Q35982462-12479719-5B51-4394-ABA7-D548D55D6E49

Q35982462-1AF6A982-5B52-4D66-B921-DB90A63AA208

Q35982462-1FE19393-A7AD-4B52-9CC9-63316A33CE6E

Q35982462-2F0F0BF0-C12A-4E48-8E19-A4CBFBE0A521

Q35982462-318BD1B7-22D2-4816-9A1D-A8E5300A2754

Q35982462-4321E773-8EF8-44C0-889C-AE5DAFDEE218

Q35982462-4E2B4325-7C54-4EE8-A321-B05E661B0D17

Q35982462-5AFE44DD-2C89-4583-8588-08BAFF237003

P304

Q35982462-775C7B58-DA3C-48C3-9CDF-A10234A8D2C8

P31

Q35982462-9EC0176F-7584-47CE-A1D3-356622EAFDDD

P356

Q35982462-DC32CD6A-B05F-4E5E-8063-6782FAB88A90

P407

Q35982462-4787311C-BAA2-47C0-A82B-C994262B17CB

P433

Q35982462-39385425-0426-4121-9A82-C8B72B0A950D

P478

Q35982462-EA108770-0604-4C6B-B5CF-ECF626F86829

P577

Q35982462-E9EFF1DA-39F6-435A-A501-A5F4FEF50162

P5875

Q35982462-D50E4726-20C0-483F-9702-2DFC5415C6F0

P698

Q35982462-7CB3D5C7-AE3D-4922-BC48-0FCBF309E023

P921

Q35982462-F8968525-F64B-4CD4-A932-EB41EEEC77FC

P932

Q35982462-54764E28-CA5E-47FA-ABF7-376760C1047B

P356

P1433

P1476

Delivery of multiple siRNAs us ...... r treatment of prostate cancer

@en

P2093

Anuradha Gullapalli

http://www.w3.org/2001/XMLSchema#string

Elizabeth M Enlow

http://www.w3.org/2001/XMLSchema#string

J Christopher Luft

http://www.w3.org/2001/XMLSchema#string

Jason P Rolland

http://www.w3.org/2001/XMLSchema#string

Joseph M DeSimone

http://www.w3.org/2001/XMLSchema#string

Kevin Chu

http://www.w3.org/2001/XMLSchema#string

Mary E Napier

http://www.w3.org/2001/XMLSchema#string

Patrick D Pohlhaus

http://www.w3.org/2001/XMLSchema#string

Shaomin Tian

http://www.w3.org/2001/XMLSchema#string

Stuart S Dunn

http://www.w3.org/2001/XMLSchema#string

P2860

Origins and Mechanisms of miRNAs and siRNAs

Recent advances with liposomes as pharmaceutical carriers

Steric stabilization of lipid/polymer particle assemblies by poly(ethylene glycol)-lipids.

KIF11 inhibition for glioblastoma treatment: reason to hope or a struggle with the brain?

Combinatorial synthesis of chemically diverse core-shell nanoparticles for intracellular delivery.

RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo.

A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy.

Potent engineered PLGA nanoparticles by virtue of exceptionally high chemotherapeutic loadings.

Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties.

Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.

P304

287-292

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/NL2035354

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51875266

http://www.w3.org/2001/XMLSchema#string

P698

22165988

http://www.w3.org/2001/XMLSchema#string

P921

P932

3358784

http://www.w3.org/2001/XMLSchema#string